Xpovio Chinese Detailed Medication Guide

Basic drug information

Common name: Seleniso

Product name:Xpovio

English name:Selinexor

1. Detailed explanation of drug ingredients

The core active ingredient of selinesol is selinesol itself, which is a highly selective inhibitor of nuclear export protein (XPO1). This ingredient can accurately interfere with the normal physiological functions of cancer cells, effectively inhibit the growth and spread of tumor cells, and provide new ideas for cancer treatment.

2. Scope of indications

Selinesol is indicated primarily for the treatment of patients with relapsed or refractory multiple myeloma (RRMM), particularly those who have not achieved remission after at least two other treatments (such as immunomodulators or proteasome inhibitors). In addition, it has also been used to treat other types of hematological malignancies, such as acute myeloid leukemia (AML), bringing new treatment hope to patients.

3. Medication methods and dose adjustment

Selinisol is usually taken orally, and the specific dosage and treatment plan need to be individually adjusted by the doctor based on the patient's specific condition and drug resistance.

Recommended dosage for adults: 80mg twice weekly. A medication cycle is 28 days. If the patient cannot tolerate this dose, the doctor may adjust the dose according to the specific situation.

Dosage: It is recommended to take selinesol after meals to ensure better absorption. Before each dose, be sure to follow your doctor's instructions to ensure the dosage is accurate. If you miss a dose, take it as soon as possible before the next dose. Do not double the dose.

Treatment course adjustment: During treatment, doctors will regularly monitor the patient's response and adjust the dose in a timely manner according to changes in the condition. If serious side effects occur, treatment may be suspended or the dose may be reduced.

4. Side effects and countermeasures

Selinisol may cause a range of side effects. Common adverse reactions include:

Blood system: anemia, leukopenia, thrombocytopenia, etc.

Digestive system: nausea, vomiting, loss of appetite, diarrhea, constipation, etc.

Nervous system: headache, fatigue, insomnia, etc.

Others: weight loss, hyponatremia, etc.

Most side effects are manageable and may improve as treatment progresses. If serious side effects occur, such as severe hyponatremia or bleeding, you should seek medical treatment immediately and follow the doctor's advice.

5. Contraindicated groups

Contraindicated in patients allergic to selinesol or any of its components.

Pregnant or nursing women should avoid use unless under the explicit guidance of a physician to avoid adverse effects on the fetus or newborn.

6. Precautions for Medication

Drug Interactions: Selinesol may interact with other drugs, especially drugs that inhibit or induce hepatic metabolic enzymes (such asCYP3A4When used together with inhibitors or inducers), the efficacy of the drug may be affected or side effects may increase. Therefore, when using other drugs, you should inform your doctor so that the medication regimen can be adjusted.

Liver function monitoring: For patients with liver disease, the dose needs to be adjusted based on the patient's condition. Patients with hepatic impairment may be more susceptible to drug accumulation and require periodic monitoring.

Regular follow-up: During treatment, regular blood tests, such as blood routine, liver and kidney function, etc., are required to ensure the safety and efficacy of the drug.

Use in special populations: For elderly patients or patients with low body weight, use with caution and adjust the dose according to the patient's health condition.

7. Storage and custody

Seleniso should be stored in a dry, cool place away from heat and moisture. Medications should be kept out of the reach of children to ensure safety. If the medicine is expired or abnormal, you should deal with it promptly and consult a doctor.

8. Drug Approval Information

Selinesol’s domestic marketing approval number isH20180054, which complies with the approval standards of the National Medical Products Administration.

9. Manufacturer Profile

Selinesol is produced byKaryopharm Therapeutics, a biopharmaceutical company dedicated to the development and innovation of cancer treatment drugs, providing high-quality drugs and services to patients around the world.

xa0

Reference materials

Karyopharm TherapeuticsOfficial website:https://www.karyopharm.com

National Medical Products Administration (NMPA) official website:https://www.nmpa.gov.cn